Bio-View Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Daniel Klain
Chief executive officer
₪2.9m
Total compensation
| CEO salary percentage | 38.0% |
| CEO tenure | 1.4yrs |
| CEO ownership | n/a |
| Management average tenure | 7.8yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation
Dec 04
Recent updates
Some Shareholders Feeling Restless Over Bio-View Ltd's (TLV:BIOV) P/E Ratio
Dec 19Shareholders Will Probably Not Have Any Issues With Bio-View Ltd's (TLV:BIOV) CEO Compensation
Dec 04Estimating The Intrinsic Value Of Bio-View Ltd (TLV:BIOV)
Feb 14Does BioView Ltd.'s (TLV:BIOV) Weak Fundamentals Mean That The Market Could Correct Its Share Price?
Jan 20What BioView Ltd.'s (TLV:BIOV) 35% Share Price Gain Is Not Telling You
Nov 29
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₪887k |
| Mar 31 2024 | n/a | n/a | ₪635k |
| Dec 31 2023 | ₪3m | ₪1m | ₪383k |
Compensation vs Market: Daniel's total compensation ($USD802.72K) is above average for companies of similar size in the IL market ($USD416.55K).
Compensation vs Earnings: Insufficient data to compare Daniel's compensation with company performance.
CEO
Daniel Klain (45 yo)
1.4yrs
Tenure
₪2,877,040
Compensation
Mr. Daniel Klain is President & CEO of Bio-View Ltd from 2023. Mr. Klain joined the Bio-View Ltd in 2006. Mr. Klain joined BioView in 2006 as a software engineer and over the past years, has filled various...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 1.4yrs | ₪2.88m | no data | |
| Vice President of Marketing | 14.5yrs | ₪759.00k | no data | |
| Deputy Chief Executive Officer | 15.8yrs | ₪858.00k | 0.36% ₪ 135.7k | |
| President & CEO of Bioview (USA) Inc. | no data | ₪929.00k | no data | |
| Chief Financial Officer | 1.4yrs | no data | no data | |
| Chief Operating Officer | 12.7yrs | ₪644.00k | no data | |
| Chief Scientific Officer | 3yrs | no data | no data |
7.8yrs
Average Tenure
48.5yo
Average Age
Experienced Management: BIOV's management team is seasoned and experienced (7.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 24.8yrs | no data | 19.68% ₪ 7.4m | |
| External Director | 9.6yrs | no data | no data | |
| External Director | 2.3yrs | no data | no data | |
| Independent External Director | 2.3yrs | no data | no data | |
| Director | 2.3yrs | no data | no data | |
| Director | 2.3yrs | ₪185.00k | no data | |
| Independent Director | 2.3yrs | no data | no data | |
| Director | 1.7yrs | no data | no data |
2.3yrs
Average Tenure
51.5yo
Average Age
Experienced Board: BIOV's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/25 01:11 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bio-View Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|